Luke Walker
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Oncology 28
- HER2/EGFR in Cancer Research 18
- Cancer Treatment and Pharmacology 17
- Lung Cancer Research Studies 4
-
- Advanced Breast Cancer Therapies 12
- Brain Metastases and Treatment 8
- Co-authors
- Diana F. Hausman (8 shared papers)Antonio Jimeno (6 shared papers)Alexander I. Spira (4 shared papers)Daniel W. Bowles (5 shared papers)Keisuke Shirai (2 shared papers)Charles M. Rudin (4 shared papers)Ian D. Schnadig (4 shared papers)Mark D. Kochenderfer (2 shared papers)
- Journals
- Cancer Research (10 papers)Annals of Oncology (10 papers)Journal of Clinical Oncology (7 papers)Clinical Pharmacokinetics (2 papers)Investigative Radiology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Luke Walker
39 papers receiving 510 citations
Peers
Comparison fields: 5 of 46
- Otorhinolaryngology 55
- Oncology 241
- Genetics 79
- Pulmonary and Respiratory Medicine 221
- Molecular Biology 239
Countries citing papers authored by Luke Walker
This map shows the geographic impact of Luke Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Walker more than expected).
Fields of papers citing papers by Luke Walker
This network shows the impact of papers produced by Luke Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Walker. The network helps show where Luke Walker may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 84 | |
| 2 | 2015 | 69 | |
| 3 | 2013 | 58 | |
| 4 | 2014 | 44 | |
| 5 | 2016 | 38 | |
| 6 | 2020 | 35 | |
| 7 | 2016 | 24 | |
| 8 | 2020 | 23 | |
| 9 | 2014 | 20 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 9 | |
| 12 | 1999 | 9 | |
| 13 | 2015 | 8 | |
| 14 | 2017 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2012 | 6 | |
| 17 | 2016 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2020 | 4 |
About Luke Walker
Luke Walker is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 40 papers that have together received 510 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Cancer Treatment and Pharmacology (17 papers), Advanced Breast Cancer Therapies (12 papers), Brain Metastases and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Lung Cancer Research Studies (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Otorhinolaryngology (55 citations), Oncology (241 citations), Genetics (79 citations), Pulmonary and Respiratory Medicine (221 citations) and Molecular Biology (239 citations). Luke Walker has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Diana F. Hausman, Antonio Jimeno, Alexander I. Spira, Daniel W. Bowles, Keisuke Shirai, Charles M. Rudin, Ian D. Schnadig, Mark D. Kochenderfer, Minsig Choi and Benjamin Levy. Their work appears in journals such as Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Clinical Pharmacokinetics and Investigative Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.